190 related articles for article (PubMed ID: 33632283)
1. Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection.
Shah AA; Igusa T; Goldman D; Li J; Casciola-Rosen L; Rosen A; Petri M
Arthritis Res Ther; 2021 Feb; 23(1):64. PubMed ID: 33632283
[TBL] [Abstract][Full Text] [Related]
2. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
3. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
Chauhan SK; Rai R; Singh VV; Rai M; Rai G
Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
[TBL] [Abstract][Full Text] [Related]
4. Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls.
Young KA; Terrell DR; Guthridge JM; Kamen DL; Gilkeson GS; Karp DR; Ishimori ML; Weisman MH; Holers VM; Harley JB; Norris JM; James JA
Lupus; 2014 Apr; 23(4):360-9. PubMed ID: 24449338
[TBL] [Abstract][Full Text] [Related]
5. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
6. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk in systemic lupus: an updated international multi-centre cohort study.
Bernatsky S; Ramsey-Goldman R; Labrecque J; Joseph L; Boivin JF; Petri M; Zoma A; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler E; Yelin E; Bae SC; Wallace DJ; Edworthy S; Jacobsen S; Gordon C; Dooley MA; Peschken CA; Hanly JG; Alarcón GS; Nived O; Ruiz-Irastorza G; Isenberg D; Rahman A; Witte T; Aranow C; Kamen DL; Steinsson K; Askanase A; Barr S; Criswell LA; Sturfelt G; Patel NM; Senécal JL; Zummer M; Pope JE; Ensworth S; El-Gabalawy H; McCarthy T; Dreyer L; Sibley J; St Pierre Y; Clarke AE
J Autoimmun; 2013 May; 42():130-5. PubMed ID: 23410586
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
Parikh-Patel A; White RH; Allen M; Cress R
Cancer Causes Control; 2008 Oct; 19(8):887-94. PubMed ID: 18386139
[TBL] [Abstract][Full Text] [Related]
9. The homogeneous multiplexed system--a new method for autoantibody profile in systemic lupus erythematosus.
Zandman-Goddard G; Gilburd B; Shovman O; Blank M; Berdichevski S; Langevitz P; Shoenfeld Y
Clin Dev Immunol; 2005 Jun; 12(2):107-11. PubMed ID: 16050141
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer.
Igusa T; Hummers LK; Visvanathan K; Richardson C; Wigley FM; Casciola-Rosen L; Rosen A; Shah AA
Ann Rheum Dis; 2018 Aug; 77(8):1179-1186. PubMed ID: 29678941
[TBL] [Abstract][Full Text] [Related]
11. RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities.
Rai R; Chauhan SK; Singh VV; Rai M; Rai G
PLoS One; 2016; 11(11):e0166312. PubMed ID: 27835693
[TBL] [Abstract][Full Text] [Related]
12. Differences in autoantibody profiles and disease activity and damage scores between childhood- and adult-onset systemic lupus erythematosus: a meta-analysis.
Livingston B; Bonner A; Pope J
Semin Arthritis Rheum; 2012 Dec; 42(3):271-80. PubMed ID: 22704358
[TBL] [Abstract][Full Text] [Related]
13. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
To CH; Petri M
Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
[TBL] [Abstract][Full Text] [Related]
14. No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis.
Rezaieyazdi Z; Tabaei S; Ravanshad Y; Akhtari J; Mehrad-Majd H
Clin Rheumatol; 2018 Jun; 37(6):1511-1519. PubMed ID: 29294194
[TBL] [Abstract][Full Text] [Related]
15. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.
Syahidatulamali CS; Wan Syamimee WG; Azwany YN; Wong KK; Che Maraina CH
J Postgrad Med; 2017; 63(4):257-261. PubMed ID: 28862243
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus.
Lewis MJ; McAndrew MB; Wheeler C; Workman N; Agashe P; Koopmann J; Uddin E; Morris DL; Zou L; Stark R; Anson J; Cope AP; Vyse TJ
J Autoimmun; 2018 Jul; 91():1-12. PubMed ID: 29576246
[TBL] [Abstract][Full Text] [Related]
17. Risk of systemic lupus erythematosus flares according to autoantibody positivity at the time of diagnosis.
Kwon OC; Park MC
Sci Rep; 2023 Feb; 13(1):3068. PubMed ID: 36810359
[TBL] [Abstract][Full Text] [Related]
18. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
[TBL] [Abstract][Full Text] [Related]
19. Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population.
Khaliq W; Qayyum R; Clough J; Vaidya D; Wolff AC; Becker DM
Breast Cancer Res Treat; 2015 Jun; 151(2):465-74. PubMed ID: 25957594
[TBL] [Abstract][Full Text] [Related]
20. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus.
Cobo-Ibáñez T; Urruticoechea-Arana A; Rúa-Figueroa I; Martín-Martínez MA; Ovalles-Bonilla JG; Galindo M; Calvo-Alén J; Olivé A; Fernández-Nebro A; Menor-Almagro R; Tomero E; Horcada L; Uriarte-Itzazelaia E; Martínez-Taboada VM; Andreu JL; Boteanu A; Narváez J; Bohorquez C; Montilla C; Santos G; Hernández-Cruz B; Vela P; Salgado E; Freire M; Hernández-Beriain JÁ; Díez-Álvarez E; Expósito L; Fernández-Berrizbeitia O; Velloso-Feijoo ML; Ibáñez-Barceló M; Lozano-Rivas N; Bonilla G; Moreno M; Raya E; Quevedo-Vila VE; Vázquez-Rodríguez TR; Ibáñez-Ruan J; Muñoz-Fernández S; Sánchez-Alonso F; Pego-Reigosa JM
Arthritis Care Res (Hoboken); 2020 Feb; 72(2):216-224. PubMed ID: 31529686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
